Learn / Activation, Mania and Psychosis
Activation, mania and psychosis
Activation, mania and psychosis — uncommon, documented, not a vibe
Serious psychiatric reactions to stimulant treatment have been recorded and are uncommon. Association is not individual causation. This page will not diagnose you, and it will not tell you that you are fine.
This is the page that has to be written carefully or not at all. Rare events get sensationalised. Common discomfort gets dismissed. People in the middle are left translating themselves into a language that only has two volumes.
1 · Statement
Prescription amphetamine treatment has been associated with an uncommon increased occurrence of psychotic symptoms compared with methylphenidate in a large observational study of young people. The events were uncommon in both groups. Association is not proof that amphetamine caused psychosis in any individual.
2 · Classification
Associated. Large new-user observational comparison; residual confounding remains possible.
3 · Papers
4 · Claim limitation
US claims data; uncommon outcome; not a randomised trial; not an Australian cohort.
Last reviewed
1 September 2026
Moran and colleagues (2019) compared new users of amphetamine versus methylphenidate in US insurance claims. Amphetamine was associated with a greater risk of a subsequent psychosis episode. Events were uncommon in both groups (0.21% versus 0.10% in the paper’s primary comparison). Observational claims data cannot prove that amphetamine caused psychosis in any one person. Residual confounding remains possible. Uncommon is not the same as unimportant for the person it happens to.
What belongs in a timeline, not a forum argument
- Unusually energised, reduced need for sleep, racing thoughts.
- Hypervigilance; a new certainty that another person or situation intends harm.
- Hearing or seeing something others do not appear to perceive.
- Severe agitation.
- Self-harm thoughts.
Recording these experiences is not an admission that a medicine “caused” them. It is how you keep the sequence available for a human who can actually help.
Sources used on this page
- Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S (2019). Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
- Australian ADHD Professionals Association (AADPA) (2022). Australian Evidence-Based Clinical Practice Guideline For Attention Deficit Hyperactivity Disorder (ADHD).
- National Institute for Health and Care Excellence (NICE) (2018). Attention deficit hyperactivity disorder: diagnosis and management (NG87).
Paradoxical.life provides evidence and self-documentation tools, not medical advice. If you have concerns about your health, medication or mental state, speak with a qualified medical practitioner.